nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—SLC15A2—multiple sclerosis	0.725	1	CbGaD
Chlorpropamide—ABCB1—Methylprednisolone—multiple sclerosis	0.0311	0.151	CbGbCtD
Chlorpropamide—CYP2C19—Prednisone—multiple sclerosis	0.0233	0.114	CbGbCtD
Chlorpropamide—ABCB1—Mitoxantrone—multiple sclerosis	0.0227	0.111	CbGbCtD
Chlorpropamide—SLC22A6—Methotrexate—multiple sclerosis	0.0212	0.103	CbGbCtD
Chlorpropamide—ABCB1—Betamethasone—multiple sclerosis	0.0202	0.0985	CbGbCtD
Chlorpropamide—ABCB1—Prednisolone—multiple sclerosis	0.0199	0.0972	CbGbCtD
Chlorpropamide—ABCB1—Prednisone—multiple sclerosis	0.0188	0.0918	CbGbCtD
Chlorpropamide—CYP2C19—Dexamethasone—multiple sclerosis	0.0146	0.071	CbGbCtD
Chlorpropamide—CYP2C9—Dexamethasone—multiple sclerosis	0.0121	0.059	CbGbCtD
Chlorpropamide—ABCB1—Dexamethasone—multiple sclerosis	0.0117	0.0573	CbGbCtD
Chlorpropamide—ABCB1—Methotrexate—multiple sclerosis	0.00944	0.046	CbGbCtD
Chlorpropamide—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00596	0.246	CbGpPWpGaD
Chlorpropamide—Water retention—Dexamethasone—multiple sclerosis	0.00233	0.0544	CcSEcCtD
Chlorpropamide—Water retention—Betamethasone—multiple sclerosis	0.00233	0.0544	CcSEcCtD
Chlorpropamide—Water retention—Prednisone—multiple sclerosis	0.00203	0.0474	CcSEcCtD
Chlorpropamide—Tolbutamide—SLC15A2—multiple sclerosis	0.00141	0.433	CrCbGaD
Chlorpropamide—Aplastic anaemia—Cladribine—multiple sclerosis	0.0011	0.0258	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Azathioprine—multiple sclerosis	0.00109	0.0254	CcSEcCtD
Chlorpropamide—Glyburide—SLC15A2—multiple sclerosis	0.00098	0.3	CrCbGaD
Chlorpropamide—Haemolytic anaemia—Cladribine—multiple sclerosis	0.000945	0.0221	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Azathioprine—multiple sclerosis	0.000897	0.0209	CcSEcCtD
Chlorpropamide—Leukopenia—Fingolimod—multiple sclerosis	0.000811	0.0189	CcSEcCtD
Chlorpropamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000803	0.0331	CbGpPWpGaD
Chlorpropamide—ABCC8—Potassium Channels—KCNA3—multiple sclerosis	0.00079	0.0326	CbGpPWpGaD
Chlorpropamide—KCNJ11—Potassium Channels—KCNA3—multiple sclerosis	0.000766	0.0316	CbGpPWpGaD
Chlorpropamide—Eosinophilia—Cladribine—multiple sclerosis	0.00073	0.017	CcSEcCtD
Chlorpropamide—Pancytopenia—Cladribine—multiple sclerosis	0.0007	0.0164	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000638	0.0149	CcSEcCtD
Chlorpropamide—Eruption—Methotrexate—multiple sclerosis	0.000626	0.0146	CcSEcCtD
Chlorpropamide—Fluid retention—Prednisolone—multiple sclerosis	0.000602	0.014	CcSEcCtD
Chlorpropamide—Pancytopenia—Azathioprine—multiple sclerosis	0.000569	0.0133	CcSEcCtD
Chlorpropamide—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.000563	0.0131	CcSEcCtD
Chlorpropamide—Erythema multiforme—Cladribine—multiple sclerosis	0.000558	0.013	CcSEcCtD
Chlorpropamide—Fluid retention—Triamcinolone—multiple sclerosis	0.000553	0.0129	CcSEcCtD
Chlorpropamide—Fluid retention—Methylprednisolone—multiple sclerosis	0.000552	0.0129	CcSEcCtD
Chlorpropamide—Pruritus—Fingolimod—multiple sclerosis	0.000523	0.0122	CcSEcCtD
Chlorpropamide—Diarrhoea—Fingolimod—multiple sclerosis	0.000506	0.0118	CcSEcCtD
Chlorpropamide—Fluid retention—Betamethasone—multiple sclerosis	0.000502	0.0117	CcSEcCtD
Chlorpropamide—Fluid retention—Dexamethasone—multiple sclerosis	0.000502	0.0117	CcSEcCtD
Chlorpropamide—Agranulocytosis—Azathioprine—multiple sclerosis	0.000499	0.0116	CcSEcCtD
Chlorpropamide—Dizziness—Fingolimod—multiple sclerosis	0.000489	0.0114	CcSEcCtD
Chlorpropamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000473	0.0195	CbGpPWpGaD
Chlorpropamide—Headache—Fingolimod—multiple sclerosis	0.000463	0.0108	CcSEcCtD
Chlorpropamide—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00046	0.0107	CcSEcCtD
Chlorpropamide—Erythema multiforme—Azathioprine—multiple sclerosis	0.000454	0.0106	CcSEcCtD
Chlorpropamide—Fluid retention—Prednisone—multiple sclerosis	0.000437	0.0102	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Cladribine—multiple sclerosis	0.00041	0.00959	CcSEcCtD
Chlorpropamide—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000403	0.00942	CcSEcCtD
Chlorpropamide—Gliclazide—ALB—multiple sclerosis	0.000402	0.123	CrCbGaD
Chlorpropamide—Anorexia—Cladribine—multiple sclerosis	0.0004	0.00933	CcSEcCtD
Chlorpropamide—Leukopenia—Azathioprine—multiple sclerosis	0.000374	0.00873	CcSEcCtD
Chlorpropamide—Decreased appetite—Cladribine—multiple sclerosis	0.000364	0.00851	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000362	0.00845	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000361	0.00844	CcSEcCtD
Chlorpropamide—ABCC8—Neuronal System—KCNA3—multiple sclerosis	0.000345	0.0142	CbGpPWpGaD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000338	0.0139	CbGpPWpGaD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000338	0.0139	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—KCNA3—multiple sclerosis	0.000334	0.0138	CbGpPWpGaD
Chlorpropamide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000334	0.00779	CcSEcCtD
Chlorpropamide—Urticaria—Cladribine—multiple sclerosis	0.000333	0.00778	CcSEcCtD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000316	0.013	CbGpPWpGaD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000316	0.013	CbGpPWpGaD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	0.000316	0.013	CbGpPWpGaD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000309	0.0128	CbGpPWpGaD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000309	0.0128	CbGpPWpGaD
Chlorpropamide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000302	0.00706	CcSEcCtD
Chlorpropamide—Pruritus—Cladribine—multiple sclerosis	0.000297	0.00693	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000296	0.00691	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000294	0.00687	CcSEcCtD
Chlorpropamide—Diarrhoea—Cladribine—multiple sclerosis	0.000287	0.0067	CcSEcCtD
Chlorpropamide—Dizziness—Cladribine—multiple sclerosis	0.000277	0.00647	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00027	0.0063	CcSEcCtD
Chlorpropamide—Vomiting—Cladribine—multiple sclerosis	0.000267	0.00623	CcSEcCtD
Chlorpropamide—Rash—Cladribine—multiple sclerosis	0.000264	0.00617	CcSEcCtD
Chlorpropamide—Anorexia—Mitoxantrone—multiple sclerosis	0.000263	0.00613	CcSEcCtD
Chlorpropamide—Headache—Cladribine—multiple sclerosis	0.000263	0.00613	CcSEcCtD
Chlorpropamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000262	0.0108	CbGpPWpGaD
Chlorpropamide—Probenecid—ALB—multiple sclerosis	0.000258	0.079	CrCbGaD
Chlorpropamide—Nausea—Cladribine—multiple sclerosis	0.000249	0.00582	CcSEcCtD
Chlorpropamide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000243	0.00566	CcSEcCtD
Chlorpropamide—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00024	0.00559	CcSEcCtD
Chlorpropamide—Eosinophilia—Methotrexate—multiple sclerosis	0.000239	0.00558	CcSEcCtD
Chlorpropamide—Diarrhoea—Azathioprine—multiple sclerosis	0.000233	0.00545	CcSEcCtD
Chlorpropamide—Pancytopenia—Methotrexate—multiple sclerosis	0.000229	0.00535	CcSEcCtD
Chlorpropamide—Dizziness—Azathioprine—multiple sclerosis	0.000225	0.00526	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00022	0.00515	CcSEcCtD
Chlorpropamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00022	0.00907	CbGpPWpGaD
Chlorpropamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00022	0.00907	CbGpPWpGaD
Chlorpropamide—Urticaria—Mitoxantrone—multiple sclerosis	0.000219	0.00511	CcSEcCtD
Chlorpropamide—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000217	0.00895	CbGpPWpGaD
Chlorpropamide—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000217	0.00895	CbGpPWpGaD
Chlorpropamide—Vomiting—Azathioprine—multiple sclerosis	0.000217	0.00506	CcSEcCtD
Chlorpropamide—Rash—Azathioprine—multiple sclerosis	0.000215	0.00502	CcSEcCtD
Chlorpropamide—Headache—Azathioprine—multiple sclerosis	0.000214	0.00499	CcSEcCtD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000211	0.00871	CbGpPWpGaD
Chlorpropamide—Glyburide—ALB—multiple sclerosis	0.000211	0.0646	CrCbGaD
Chlorpropamide—KCNJ11—Type II diabetes mellitus—MAPK1—multiple sclerosis	0.000209	0.00862	CbGpPWpGaD
Chlorpropamide—Nausea—Azathioprine—multiple sclerosis	0.000202	0.00473	CcSEcCtD
Chlorpropamide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000201	0.00469	CcSEcCtD
Chlorpropamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000201	0.00827	CbGpPWpGaD
Chlorpropamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000201	0.00827	CbGpPWpGaD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.0002	0.00824	CbGpPWpGaD
Chlorpropamide—KCNJ11—Type II diabetes mellitus—TNF—multiple sclerosis	0.000199	0.00821	CbGpPWpGaD
Chlorpropamide—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000198	0.00816	CbGpPWpGaD
Chlorpropamide—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000198	0.00816	CbGpPWpGaD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000194	0.00799	CbGpPWpGaD
Chlorpropamide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000193	0.00794	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000189	0.0044	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000185	0.00431	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000185	0.00431	CcSEcCtD
Chlorpropamide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000183	0.00427	CcSEcCtD
Chlorpropamide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000183	0.00754	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000183	0.00427	CcSEcCtD
Chlorpropamide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000183	0.00426	CcSEcCtD
Chlorpropamide—Anorexia—Betamethasone—multiple sclerosis	0.00018	0.0042	CcSEcCtD
Chlorpropamide—Anorexia—Dexamethasone—multiple sclerosis	0.00018	0.0042	CcSEcCtD
Chlorpropamide—Urticaria—Prednisolone—multiple sclerosis	0.00018	0.00419	CcSEcCtD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000178	0.00735	CbGpPWpGaD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000178	0.00735	CbGpPWpGaD
Chlorpropamide—Vomiting—Mitoxantrone—multiple sclerosis	0.000175	0.00409	CcSEcCtD
Chlorpropamide—Rash—Mitoxantrone—multiple sclerosis	0.000174	0.00406	CcSEcCtD
Chlorpropamide—Headache—Mitoxantrone—multiple sclerosis	0.000173	0.00403	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000173	0.00712	CbGpPWpGaD
Chlorpropamide—Dyspepsia—Betamethasone—multiple sclerosis	0.000166	0.00388	CcSEcCtD
Chlorpropamide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000166	0.00388	CcSEcCtD
Chlorpropamide—Urticaria—Triamcinolone—multiple sclerosis	0.000165	0.00386	CcSEcCtD
Chlorpropamide—Urticaria—Methylprednisolone—multiple sclerosis	0.000165	0.00385	CcSEcCtD
Chlorpropamide—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000164	0.00677	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000164	0.00677	CbGpPWpGaD
Chlorpropamide—Decreased appetite—Betamethasone—multiple sclerosis	0.000164	0.00383	CcSEcCtD
Chlorpropamide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000164	0.00383	CcSEcCtD
Chlorpropamide—Nausea—Mitoxantrone—multiple sclerosis	0.000164	0.00382	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000163	0.0038	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000163	0.0038	CcSEcCtD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000163	0.0067	CbGpPWpGaD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000163	0.0067	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00016	0.0066	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000157	0.00647	CbGpPWpGaD
Chlorpropamide—Anorexia—Prednisone—multiple sclerosis	0.000157	0.00366	CcSEcCtD
Chlorpropamide—Leukopenia—Methotrexate—multiple sclerosis	0.000151	0.00352	CcSEcCtD
Chlorpropamide—Urticaria—Dexamethasone—multiple sclerosis	0.00015	0.0035	CcSEcCtD
Chlorpropamide—Urticaria—Betamethasone—multiple sclerosis	0.00015	0.0035	CcSEcCtD
Chlorpropamide—Dizziness—Prednisolone—multiple sclerosis	0.000149	0.00349	CcSEcCtD
Chlorpropamide—Pruritus—Triamcinolone—multiple sclerosis	0.000147	0.00344	CcSEcCtD
Chlorpropamide—Pruritus—Methylprednisolone—multiple sclerosis	0.000147	0.00343	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000146	0.00604	CbGpPWpGaD
Chlorpropamide—Dyspepsia—Prednisone—multiple sclerosis	0.000145	0.00338	CcSEcCtD
Chlorpropamide—Decreased appetite—Prednisone—multiple sclerosis	0.000143	0.00334	CcSEcCtD
Chlorpropamide—Rash—Prednisolone—multiple sclerosis	0.000143	0.00333	CcSEcCtD
Chlorpropamide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000142	0.00331	CcSEcCtD
Chlorpropamide—Headache—Prednisolone—multiple sclerosis	0.000142	0.00331	CcSEcCtD
Chlorpropamide—Dizziness—Triamcinolone—multiple sclerosis	0.000137	0.00321	CcSEcCtD
Chlorpropamide—Dizziness—Methylprednisolone—multiple sclerosis	0.000137	0.0032	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000134	0.00314	CcSEcCtD
Chlorpropamide—Nausea—Prednisolone—multiple sclerosis	0.000134	0.00314	CcSEcCtD
Chlorpropamide—Pruritus—Betamethasone—multiple sclerosis	0.000133	0.00312	CcSEcCtD
Chlorpropamide—Pruritus—Dexamethasone—multiple sclerosis	0.000133	0.00312	CcSEcCtD
Chlorpropamide—Vomiting—Triamcinolone—multiple sclerosis	0.000132	0.00309	CcSEcCtD
Chlorpropamide—Vomiting—Methylprednisolone—multiple sclerosis	0.000132	0.00308	CcSEcCtD
Chlorpropamide—Rash—Triamcinolone—multiple sclerosis	0.000131	0.00306	CcSEcCtD
Chlorpropamide—Anorexia—Methotrexate—multiple sclerosis	0.000131	0.00306	CcSEcCtD
Chlorpropamide—Rash—Methylprednisolone—multiple sclerosis	0.000131	0.00305	CcSEcCtD
Chlorpropamide—Urticaria—Prednisone—multiple sclerosis	0.00013	0.00305	CcSEcCtD
Chlorpropamide—Headache—Triamcinolone—multiple sclerosis	0.00013	0.00304	CcSEcCtD
Chlorpropamide—Headache—Methylprednisolone—multiple sclerosis	0.00013	0.00303	CcSEcCtD
Chlorpropamide—Diarrhoea—Betamethasone—multiple sclerosis	0.000129	0.00301	CcSEcCtD
Chlorpropamide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000129	0.00301	CcSEcCtD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000129	0.0053	CbGpPWpGaD
Chlorpropamide—Dizziness—Dexamethasone—multiple sclerosis	0.000125	0.00291	CcSEcCtD
Chlorpropamide—Dizziness—Betamethasone—multiple sclerosis	0.000125	0.00291	CcSEcCtD
Chlorpropamide—Nausea—Triamcinolone—multiple sclerosis	0.000123	0.00288	CcSEcCtD
Chlorpropamide—Nausea—Methylprednisolone—multiple sclerosis	0.000123	0.00288	CcSEcCtD
Chlorpropamide—Dyspepsia—Methotrexate—multiple sclerosis	0.000121	0.00282	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000121	0.00497	CbGpPWpGaD
Chlorpropamide—Vomiting—Dexamethasone—multiple sclerosis	0.00012	0.0028	CcSEcCtD
Chlorpropamide—Vomiting—Betamethasone—multiple sclerosis	0.00012	0.0028	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000119	0.00492	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000119	0.00492	CbGpPWpGaD
Chlorpropamide—Decreased appetite—Methotrexate—multiple sclerosis	0.000119	0.00279	CcSEcCtD
Chlorpropamide—Rash—Dexamethasone—multiple sclerosis	0.000119	0.00278	CcSEcCtD
Chlorpropamide—Rash—Betamethasone—multiple sclerosis	0.000119	0.00278	CcSEcCtD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000119	0.0049	CbGpPWpGaD
Chlorpropamide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000119	0.00277	CcSEcCtD
Chlorpropamide—Headache—Dexamethasone—multiple sclerosis	0.000118	0.00276	CcSEcCtD
Chlorpropamide—Headache—Betamethasone—multiple sclerosis	0.000118	0.00276	CcSEcCtD
Chlorpropamide—Pruritus—Prednisone—multiple sclerosis	0.000116	0.00271	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000116	0.00478	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Prednisone—multiple sclerosis	0.000112	0.00263	CcSEcCtD
Chlorpropamide—Nausea—Dexamethasone—multiple sclerosis	0.000112	0.00262	CcSEcCtD
Chlorpropamide—Nausea—Betamethasone—multiple sclerosis	0.000112	0.00262	CcSEcCtD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000112	0.00461	CbGpPWpGaD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000111	0.00456	CbGpPWpGaD
Chlorpropamide—Urticaria—Methotrexate—multiple sclerosis	0.000109	0.00255	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000109	0.00448	CbGpPWpGaD
Chlorpropamide—Dizziness—Prednisone—multiple sclerosis	0.000109	0.00254	CcSEcCtD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000107	0.00443	CbGpPWpGaD
Chlorpropamide—Vomiting—Prednisone—multiple sclerosis	0.000104	0.00244	CcSEcCtD
Chlorpropamide—Rash—Prednisone—multiple sclerosis	0.000104	0.00242	CcSEcCtD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000103	0.00426	CbGpPWpGaD
Chlorpropamide—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000103	0.00425	CbGpPWpGaD
Chlorpropamide—Headache—Prednisone—multiple sclerosis	0.000103	0.0024	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000102	0.00422	CbGpPWpGaD
Chlorpropamide—Nausea—Prednisone—multiple sclerosis	9.76e-05	0.00228	CcSEcCtD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.74e-05	0.00402	CbGpPWpGaD
Chlorpropamide—Pruritus—Methotrexate—multiple sclerosis	9.71e-05	0.00227	CcSEcCtD
Chlorpropamide—ABCC8—Neuronal System—BCHE—multiple sclerosis	9.67e-05	0.00399	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	9.47e-05	0.00391	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	9.47e-05	0.00391	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Methotrexate—multiple sclerosis	9.39e-05	0.00219	CcSEcCtD
Chlorpropamide—KCNJ11—Neuronal System—BCHE—multiple sclerosis	9.38e-05	0.00387	CbGpPWpGaD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	9.36e-05	0.00386	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.34e-05	0.00385	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.34e-05	0.00385	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	9.3e-05	0.00384	CbGpPWpGaD
Chlorpropamide—Dizziness—Methotrexate—multiple sclerosis	9.08e-05	0.00212	CcSEcCtD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.77e-05	0.00362	CbGpPWpGaD
Chlorpropamide—Vomiting—Methotrexate—multiple sclerosis	8.73e-05	0.00204	CcSEcCtD
Chlorpropamide—Rash—Methotrexate—multiple sclerosis	8.66e-05	0.00202	CcSEcCtD
Chlorpropamide—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	8.64e-05	0.00356	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	8.64e-05	0.00356	CbGpPWpGaD
Chlorpropamide—Headache—Methotrexate—multiple sclerosis	8.6e-05	0.00201	CcSEcCtD
Chlorpropamide—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.52e-05	0.00351	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.52e-05	0.00351	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.31e-05	0.00343	CbGpPWpGaD
Chlorpropamide—Nausea—Methotrexate—multiple sclerosis	8.15e-05	0.0019	CcSEcCtD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.14e-05	0.00336	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	8.07e-05	0.00333	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.97e-05	0.00329	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—SRM—multiple sclerosis	7.94e-05	0.00327	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD28—multiple sclerosis	7.84e-05	0.00323	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—SRM—multiple sclerosis	7.7e-05	0.00318	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.7e-05	0.00317	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	7.5e-05	0.00309	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	7.44e-05	0.00307	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD40—multiple sclerosis	7.15e-05	0.00295	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	7.05e-05	0.00291	CbGpPWpGaD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.96e-05	0.00287	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.93e-05	0.00286	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	6.91e-05	0.00285	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.81e-05	0.00281	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.44e-05	0.00266	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.43e-05	0.00265	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.31e-05	0.0026	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.31e-05	0.0026	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	6.21e-05	0.00256	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	6.18e-05	0.00255	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.13e-05	0.00253	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.04e-05	0.00249	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	5.81e-05	0.00239	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	5.76e-05	0.00237	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.69e-05	0.00234	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CYP24A1—multiple sclerosis	5.6e-05	0.00231	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—CYP27B1—multiple sclerosis	5.6e-05	0.00231	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD86—multiple sclerosis	5.59e-05	0.00231	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL10—multiple sclerosis	5.48e-05	0.00226	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	5.48e-05	0.00226	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CYP27B1—multiple sclerosis	5.43e-05	0.00224	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—CYP24A1—multiple sclerosis	5.43e-05	0.00224	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL4—multiple sclerosis	5.33e-05	0.0022	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	5.26e-05	0.00217	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	5.21e-05	0.00215	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—GPC5—multiple sclerosis	5.12e-05	0.00211	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—GPC5—multiple sclerosis	4.96e-05	0.00205	CbGpPWpGaD
Chlorpropamide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.95e-05	0.00204	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—FAS—multiple sclerosis	4.91e-05	0.00203	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	4.89e-05	0.00201	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	4.83e-05	0.00199	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.78e-05	0.00197	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	4.69e-05	0.00193	CbGpPWpGaD
Chlorpropamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.51e-05	0.00186	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	4.41e-05	0.00182	CbGpPWpGaD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.34e-05	0.00179	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—RRM1—multiple sclerosis	4.24e-05	0.00175	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.22e-05	0.00174	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—RRM1—multiple sclerosis	4.11e-05	0.0017	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.08e-05	0.00168	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.03e-05	0.00166	CbGpPWpGaD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.01e-05	0.00165	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—SRM—multiple sclerosis	3.99e-05	0.00164	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—POMC—multiple sclerosis	3.7e-05	0.00152	CbGpPWpGaD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.66e-05	0.00151	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.64e-05	0.0015	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.64e-05	0.0015	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.63e-05	0.0015	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.53e-05	0.00146	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	3.4e-05	0.0014	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.32e-05	0.00137	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.32e-05	0.00137	CbGpPWpGaD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.28e-05	0.00135	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.22e-05	0.00133	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.99e-05	0.00123	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.88e-05	0.00119	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.86e-05	0.00118	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.83e-05	0.00117	CbGpPWpGaD
Chlorpropamide—ABCC8—Neuronal System—MAPK1—multiple sclerosis	2.83e-05	0.00117	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CYP24A1—multiple sclerosis	2.81e-05	0.00116	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—CYP27B1—multiple sclerosis	2.81e-05	0.00116	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.75e-05	0.00113	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.75e-05	0.00113	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	2.74e-05	0.00113	CbGpPWpGaD
Chlorpropamide—KCNJ11—Neuronal System—MAPK1—multiple sclerosis	2.74e-05	0.00113	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—GPC5—multiple sclerosis	2.57e-05	0.00106	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.45e-05	0.00101	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—BCHE—multiple sclerosis	2.44e-05	0.001	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.43e-05	0.001	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—BCHE—multiple sclerosis	2.36e-05	0.000974	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—SRM—multiple sclerosis	2.3e-05	0.000948	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—SRM—multiple sclerosis	2.24e-05	0.000925	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.23e-05	0.000921	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.21e-05	0.00091	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.17e-05	0.000897	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.13e-05	0.000878	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—RRM1—multiple sclerosis	2.13e-05	0.000878	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—SRM—multiple sclerosis	2.1e-05	0.000864	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.09e-05	0.00086	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.05e-05	0.000844	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.94e-05	0.000801	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.92e-05	0.000793	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.65e-05	0.000681	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.62e-05	0.000668	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.62e-05	0.000668	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.58e-05	0.000653	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.58e-05	0.000652	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.58e-05	0.000652	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.52e-05	0.000627	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.48e-05	0.000611	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000609	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000609	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—APOE—multiple sclerosis	1.47e-05	0.000604	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—GPC5—multiple sclerosis	1.45e-05	0.000596	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.44e-05	0.000595	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—APOE—multiple sclerosis	1.42e-05	0.000586	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.42e-05	0.000585	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000557	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.29e-05	0.000533	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—POMC—multiple sclerosis	1.26e-05	0.000519	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.23e-05	0.000506	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—BCHE—multiple sclerosis	1.22e-05	0.000504	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—POMC—multiple sclerosis	1.22e-05	0.000503	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—RRM1—multiple sclerosis	1.2e-05	0.000494	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ALB—multiple sclerosis	1.15e-05	0.000473	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000462	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ALB—multiple sclerosis	1.11e-05	0.000459	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.11e-05	0.000456	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.1e-05	0.000455	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.08e-05	0.000446	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.03e-05	0.000425	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.52e-06	0.000393	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.68e-06	0.000358	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.18e-06	0.000337	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.46e-06	0.000308	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.46e-06	0.000308	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—APOE—multiple sclerosis	7.36e-06	0.000303	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—BCHE—multiple sclerosis	7.05e-06	0.000291	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.92e-06	0.000285	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—BCHE—multiple sclerosis	6.88e-06	0.000284	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.8e-06	0.00028	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.43e-06	0.000265	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—POMC—multiple sclerosis	6.32e-06	0.000261	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ALB—multiple sclerosis	5.76e-06	0.000238	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—APOE—multiple sclerosis	4.24e-06	0.000175	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—APOE—multiple sclerosis	4.14e-06	0.000171	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—APOE—multiple sclerosis	3.87e-06	0.000159	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—POMC—multiple sclerosis	3.64e-06	0.00015	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—POMC—multiple sclerosis	3.56e-06	0.000147	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—POMC—multiple sclerosis	3.32e-06	0.000137	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ALB—multiple sclerosis	3.32e-06	0.000137	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ALB—multiple sclerosis	3.24e-06	0.000134	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ALB—multiple sclerosis	3.03e-06	0.000125	CbGpPWpGaD
